• ⚠️ UK Access Block Notice: Beginning July 1, 2025, this site will no longer be accessible from the United Kingdom. This is a voluntary decision made by the site's administrators. We were not forced or ordered to implement this block.

SentimentalTrip

SentimentalTrip

Member
Mar 30, 2023
52
I was reading the PPEH (2022 edition) and I feel like I had completely glossed over the part where he discusses Amitryptiline. He rates it a 7/10 in terms of peacefulness. It seems as easy to source as SN. The only downside seems to be that it can take up to 24 hours to die using this method, so one would have to be sure one would be left alone for a long time. I'm not in a place in life right now where I'd be alone for that long, but I might be in a year or so. I'm thinking this could be a good way to CTB. Anyone know of any other downsides?
 
  • Like
Reactions: Incompatible-444
R

rekt

Member
Jul 31, 2025
59
According to the 2025 edition PPH, Amitryptyline is the worst of the three Cardiac drugs that are discussed. Propoxyphene is the most peaceful and effective of the three but the hardest to source, while Chloroquine is said to be the easiest to source and a better overall option than Amitryptyline.

The PPH 2025 edition has a chart comparing the three of them in various metrics, and Amitryptyline is rated 6/10 for reliability, which is lower than Propo and Chloro.

I think the bottom line is that Amitryptyline is still going to be hard to source for people in the developed world because it's prescription only. Sourcing these products is always the main issue for most people.
 
  • Like
  • Informative
Reactions: Aiyuxiao, Forveleth and Incompatible-444
sancta-simplicitas

sancta-simplicitas

Wizard
Dec 14, 2023
600
According to the 2025 edition PPH, Amitryptyline is the worst of the three Cardiac drugs that are discussed. Propoxyphene is the most peaceful and effective of the three but the hardest to source, while Chloroquine is said to be the easiest to source and a better overall option than Amitryptyline.

The PPH 2025 edition has a chart comparing the three of them in various metrics, and Amitryptyline is rated 6/10 for reliability, which is lower than Propo and Chloro.

I think the bottom line is that Amitryptyline is still going to be hard to source for people in the developed world because it's prescription only. Sourcing these products is always the main issue for most people.
Doctors tend to absolutely love prescribing antidepressants. It may take a while, but "trying" several SSRIs, SNRIs and uncategorized ADs such as Remeron and reporting no effect (which is common, since they lack clinical effect) will eventually lead to tricyclics. I even know someone who's on them for PMDS.
 

Similar threads

A
Replies
2
Views
100
Suicide Discussion
Astronica
A
DarkRange55
Replies
2
Views
95
Offtopic
Forever Sleep
F
EternalHunger
Replies
9
Views
235
Suicide Discussion
EternalHunger
EternalHunger
OhhDrugzZ
Replies
4
Views
384
Suicide Discussion
Kali_Yuga13
Kali_Yuga13